Abstract

Hepatoblasts, hepatic stem/progenitor cells in liver development, have a high proliferative potential and the ability to differentiate into both hepatocytes and cholangiocytes. In regenerative medicine and drug screening for the treatment of severe liver diseases, human induced pluripotent stem (iPS) cell-derived mature functional hepatocytes are considered to be a potentially good cell source. However, induction of proliferation of these cells is difficult ex vivo. To circumvent this problem, we generated hepatic progenitor-like cells from human iPS cells using serial cytokine treatments in vitro. Highly proliferative hepatic progenitor-like cells were purified by fluorescence-activated cell sorting using antibodies against CD13 and CD133 that are known cell surface markers of hepatic stem/progenitor cells in fetal and adult mouse livers. When the purified CD13highCD133+ cells were cultured at a low density with feeder cells in the presence of suitable growth factors and signaling inhibitors (ALK inhibitor A-83-01 and ROCK inhibitor Y-27632), individual cells gave rise to relatively large colonies. These colonies consisted of two types of cells expressing hepatocytic marker genes (hepatocyte nuclear factor 4α and α-fetoprotein) and a cholangiocytic marker gene (cytokeratin 7), and continued to proliferate over long periods of time. In a spheroid formation assay, these cells were found to express genes required for mature liver function, such as cytochrome P450 enzymes, and secrete albumin. When these cells were cultured in a suitable extracellular matrix gel, they eventually formed a cholangiocytic cyst-like structure with epithelial polarity, suggesting that human iPS cell-derived hepatic progenitor-like cells have a bipotent differentiation ability. Collectively these data indicate that this novel procedure using an in vitro expansion system is useful for not only liver regeneration but also for the determination of molecular mechanisms that regulate liver development.

Highlights

  • The liver is the largest internal organ in mammals and plays an important role in metabolism

  • We showed that CD13 and CD133 are specific cell surface markers of hepatic progenitor-like cells (HPCs) derived from human induced pluripotent stem (iPS) cells

  • These results suggest that somatic and cancer stem/progenitor cells share similar cell surface proteins

Read more

Summary

Introduction

The liver is the largest internal organ in mammals and plays an important role in metabolism. It performs various functions including glycogen storage, decomposition of red blood cells, plasma protein synthesis, and detoxification. Because of these many functions, it is difficult to construct an artificial liver replacement. Liver transplantation is considered the only effective treatment for end-stage liver diseases. It is limited by the shortage of suitable donor organs, the risk of rejection, infections, and lifelong immunosuppression. Generation of hepatic cells using iPS technology may be beneficial for the treatment of severe liver diseases, screening of drug toxicities, and basic research of several hepatocytic disorders

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call